The effect of 4H-3-methylcarboxamide-1,3-benzoxazine-2-one (FI 6654) on monoaminoxidase and cerebral 5-HT.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001681:Biological Assay; D001921:Brain / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D004357:Drug Synergism; D004569:Electroencephalography; D007099:Imipramine / Q000494:pharmacology; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008660:Metabolism / Q000187:drug effects; D051379:Mice; D008928:Mitochondria / Q000201:enzymology; D008930:Mitochondria, Liver / Q000201:enzymology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010078:Oxazines / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D014363:Tryptamines / Q000494:pharmacology / Q000633:toxicity
D008996:Monoamine Oxidase Inhibitors; D010078:Oxazines; D014363:Tryptamines; D012701:Serotonin; D006916:5-Hydroxytryptophan; D007490:Iproniazid; D007099:Imipramine